Trials / NCT04983914
Retrospective NIS to Evaluate the Patient Benefit of TES
Completed Observational Natural history / observational
- Sponsor
- Okuvision GmbH
- Treatment
- Transcorneal Electrostimulation via OkuStim System
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- Any to no upper limit
- Enrollment
- 49 participants
- Started
- 2021-09-06
- Main results expected
- 2022-08-19
- Results posted
- Not yet
- Record last updated
- 2022-08-22
What the study is testing
In this retrospective non-interventional study (NIS), the subjective and objective benefit of patients with retinitis pigmentosa (and other dystrophies like Usher, Choroideremia or cone-rod dystrophy), who have been prescribed the therapy of transcorneal electrostimulation (TcES) with the OkuStim System, is assessed.
Where it runs
Germany (3)
- Universitätsklinikum Heidelberg, Augenklinik, Heidelberg
- Klinikum Stuttgart gKAöR, Augenklinik Standort Mitte (Katharinenhospital), Stuttgart
- Universitäts-Augenklinik Tübingen, Abt. für Augenheilkunde, Tübingen
Switzerland (1)
- Universitätsspital Basel, Augenklinik, Basel